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Rabies virus nucleoprotein (N) encapsidates negative-strand genomic RNA in vivo, and this RNA–N complex, together with
the nominal viral phosphoprotein (P) and RNA polymerase (L), forms the active cytoplasmic ribonucleoprotein (RNP) complex
in virus-infected cells and the RNP core in virus particles. The RNP complex is capable of initiating viral RNA transcription
and replication in vivo and in vitro. To obtain insight into the events leading to the formation of the RNA–N complex, we have
investigated the interaction between rabies virus N and the positive-strand leader RNA transcript. Binding studies revealed
that recombinant N binds preferentially to rabies virus leader RNA and that N binding to leader RNA was 5 to 10 times
stronger than to nonleader RNA. Encapsidation of leader RNA by N could be competetively inhibited by unlabeled leader RNA
but not by nonleader RNA. Furthermore, N protein encapsidation of nonleader RNA but not the leader RNA was inhibited
when P was simultaneously added into the encapsidation reaction, indicating that P helps confer the specificity of leader RNA
encapsidation by N. The initiation signal for leader RNA encapsidation by N has been mapped to nucleotides 20–30 of the
RNA sequence which is A rich. Studies with N-deletion mutants indicate that the intact N is required to encapsidate RNA,
since deletion of amino acid residues from either the N- or the C-terminus of N abolishes the ability of N to encapsidate
leader RNA. © 1998 Academic Press
INTRODUCTION
Rabies virus is a single-strand, negative-sense RNA virus
of the family Rhabdoviridae. Its nonsegmented genomic
RNA acts as a template for both transcription and replica-
tion. During the transcription process, a positive-strand
leader RNA and five monocistronic mRNAs are synthe-
sized, whereas during the RNA replication process, a full-
length, positive-strand RNA (replicative intermediate) is syn-
thesized, which serves as the template for the synthesis of
progeny negative-strand genomic RNA (Wunner, 1991). The
progeny genomic RNA is encapsidated with nucleoprotein
(N) and this RNA–N complex, together with the nominal
viral phosphoprotein (P, also designated NS or M1) and
RNA polymerase (L), forms the active cytoplasmic ribonu-
cleoprotein (RNP) complex in virus-infected cells and the
RNP core in virus particles (Sokol et al., 1971). The RNP
complex alone is capable of initiating viral RNA transcrip-
tion and replication in vivo and in vitro. Recent studies of
rabies viral protein functions using reverse genetics dem-
onstrated that N, P, and L in the RNP complex are all
required for rabies virus RNA transcription and replication
(Conzelmann and Schnell 1994; Schnell et al., 1994). How-
ever, the sequence of events, specificity, and mode(s) of
interaction between each of these proteins and between
these proteins and the genomic RNA which results in viral
RNA transcription and replication has not been defined.
It is possible that N plays a crucial role in the transition
from viral RNA transcription to replication by encapsidat-
ing the positive-strand leader RNA, the first viral products
made in an infected cell, and preventing them from
further initiating genomic RNA transcription (Wunner,
1991). In vesicular stomatitis virus (VSV), another rhab-
dovirus, it has been shown in vitro that N alone can
support the transition from transcription to replication
(Patton et al., 1984) and that N preferentially interacts
with positive-strand leader RNA (Blumberg et al., 1983).
Detailed studies of the interaction between VSV N and
positive-strand RNA have demonstrated that the amino
acid residues at the C-terminus of N are critical for RNA
encapsidation, since removal of 10 amino acids from the
C-terminus of N abolishes its RNA binding capacity (Ban-
erjee et al., 1989). Blumberg et al. (1983) showed that the
encapsidation initiation signal on the positive-strand
leader RNA of VSV resides within the first 14 nucleotides,
while Moyer et al. (1991) proposed that N encapsidation
of VSV leader RNA initiates internally at nucleotides
14–16 and that subsequently RNA encapsidation by N
proceeds bidirectionally toward the 39 and 59 ends of the
RNA. The interaction between rabies virus N and the
positive-strand leader RNA has not been studied as
extensively.
Previously, we (Fu et al., 1994) and others (Chenik et
al., 1994) studying the interaction between rabies virus N
and P found that both the C- and the N-termini of P are
involved in binding to N. In the present study, we have
investigated the specificity and mode of interaction be-1 To whom reprint requests should be addressed.
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tween rabies virus N and the positive-strand leader RNA
in vitro and found that rabies virus N binds specifically to
a site within nucleotides 20–30 of positive-strand leader
RNA. Deletion of 45 amino acids from either the N- or the
C-terminus of N abolishes the ability of N to encapsidate
leader RNA.
RESULTS
Recombinant rabies virus N preferentially
encapsidates leader RNA
To study the interaction of rabies virus N and viral-
specific RNA, three radiolabeled RNA transcripts repre-
senting rabies virus positive-strand leader RNA (L-70),
the 59 end of rabies virus N mRNA (N-70), and a control
nonviral RNA (bluescript RNA, B-70) were produced by in
vitro RNA transcription and added to recombinant rabies
virus N purified from insect cells (Fu et al., 1991) for
encapsidation. As shown in Fig. 1A, recombinant N
bound to all three RNA transcripts, as evidenced by
retardation of the RNA transcripts in the gel shift assay.
However, the recombinant N bound to the leader RNA
more efficiently than to the other nonleader transcripts.
The lower band in Fig. 1 represents digested or unbound
RNA. The interaction between recombinant N and the
rabies virus leader RNA was at least 3 times greater than
that between recombinant N and N mRNA and 10 times
greater than that between recombinant N and the control
RNA, as determined by the amount of radioactivity in
each of the gel bands (Fig. 1B). When normalized by the
number of U residues in each of the transcripts (16, 40,
and 17 U residues, respectively, of L-70, N-70, and B-70),
N bound to the leader RNA at least 5 times stronger than
to the N mRNA (N-70) and 10 times stronger than to the
nonviral RNA (B-70). To further demonstrate the specific-
ity of N encapsidation of leader RNA, the encapsidation
of labeled leader RNA by N protein was competed with
an equal molar amount of unlabeled leader RNA L-70 or
nonviral RNA B-70. As shown in Fig. 2, the unlabeled
leader RNA (L-70) inhibited the N encapsidation of la-
beled leader RNA by more than 70% while unlabeled
nonleader RNA (B-70) transcript inhibited the specific
encapsidation by only 25%. This result indicates that
recombinant N preferentially binds to the positive-strand
leader RNA over viral mRNA and nonviral RNA.
To study further the encapsidation of analogous pos-
itive-strand intermediate genomic RNA, four RNA tran-
scripts were synthesized, which contained 70, 200, 400,
FIG. 1. In vitro encapsidation of rabies virus positive-strand leader RNA, N–RNA, and nonviral RNA by N. Rabies virus positive-strand leader RNA
(L-70), rabies virus N RNA (N-70), and bluescript RNA (B-70) transcripts were made and labeled with [32P]UTP by in vitro transcription and interacted
with recombinant rabies virus N protein purified from insect cells. Each of the transcripts without N protein was included as a control. The complexes
formed were subjected to RNase digestion and then electrophoresis on a 4% polyacrylamide gel. The gels were dried and autoradiographed (A). The
banded materials were excised from the gel and the radioactivity present in the bands was measured by scintillation spectrometry (B).
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and 800 nucleotides, respectively. All four RNA tran-
scripts corresponded to the 59 end of the full-length
positive-strand intermediate RNA in viral RNA replica-
tion, with the leader RNA sequence and leader RNA–N
mRNA nucleotide junction followed by various amounts
of downstream N mRNA sequences. As shown in Fig. 3,
the in vitro encapsidation of rabies virus-specific RNA by
recombinant N appeared to be dependent on the length
of the viral RNA transcript. The RNA transcript of 70
nucleotides yielded the greatest binding, the transcript
length of 200 nucleotides showed about 50% binding,
and RNA transcripts with a length greater than 400 nu-
cleotides showed minimal binding (10 times less than
the transcript of 70 nucleotides).
Rabies virus P helps confer the specificity to
encapsidation of leader RNA by N
It has been reported that VSV N binds RNA nonspecifi-
cally and that VSV P confers the specificity of the VSV N
binding to VSV leader RNA (Banerjee et al., 1989; Das and
Banerjee 1992). To study the effect of rabies virus P in
conferring the specificity to rabies virus N encapsidation of
rabies virus leader RNA, the recombinant N–P complex (3
mg) was purified from insect cells (Fu et al., 1994) and
added to radiolabeled RNA transcripts (L-70, N-70, and
B-70). Alternatively, recombinant N (2 mg) and P (1 mg) were
purified individually from insect cells (Fu et al., 1991; 1994)
and added simultaneously (not as preformed N–P complex)
to RNA transcripts in the encapsidation reaction. As shown
in Fig. 4A, the N–P complex purified from insect cells, in
comparison with N alone, reduced the specific binding of N,
markedly and uniformly, to all three RNA transcripts, indi-
cating that preformed N–P complex reduced the binding
activity of N to RNA but did not confer the specificity of N
binding to leader RNA. In contrast, addition of P and N
simultaneously to the radiolabeled RNA transcripts did not
affect the binding of N to the positive-strand leader RNA
(Fig. 4B), even when the N:P ratio was in the range from
1:0.5 to 1:8 (data not shown). Rather, the simultaneous
addition of P and N markedly reduced the encapsidation of
FIG. 2. Competition of the specific encapsidation of rabies virus positive-strand leader RNA with unlabeled leader RNA and nonleader RNA. Rabies
virus positive-strand leader RNA (L-70) was made and labeled with [32P]UTP by in vitro transcription and interacted with recombinant rabies virus N
purified from insect cells. The transcripts without N were included as a control. Unlabeled L-70 and B-70 RNA transcripts were added into the
encapsidation reaction at equal molar ratio. The complexes formed were subjected to RNase digestion and then electrophoresis on a 4%
polyacrylamide gel. The gels were dried and autoradiographed (A). The banded materials were excised from the gel and the radioactivity present in
the bands was measured by scintillation spectrometry (B).
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N mRNA (N-70) by N and completely abolished the minimal
encapsidation of nonviral RNA (B-70) by N (Fig. 4B), sug-
gesting that P helps confer the specificity of N binding and
selective encapsidation of leader RNA by reducing binding
of N to nonleader RNA without changing the encapsidation
efficiency for the leader RNA. In addition, P alone did not
bind to any of the RNA transcripts (Fig. 4B).
Mapping the initiation site(s) on the leader RNA for
encapsidation by N protein
To delineate the initiation site on rabies virus leader
RNA for encapsidation by N, 12 shortened leader RNA
transcripts were initially made, with 6 of them having the
first 10, 20, 30, 40, 50, or 60 nucleotides of the leader RNA
sequence and the other 6 lacking the first 10, 20, 30, 40,
50, or 60 nucleotides from the 59 end of the leader RNA,
respectively. These deletion mutants are depicted in Fig.
5A and the encapsidation results are shown in Fig. 5B.
All the leader RNA transcripts with deletions that con-
tained nucleotides 20–30 (L59-60, L59-50, L59-40, L59-30,
L39-60, and L39-50) were efficiently encapsidated, while
those which lacked nucleotides 20–30 (L59-20, L59-10,
L39-40, L39-30, L39-20, and L39-10) were less or not effi-
ciently encapsidated. These results indicate that the ini-
tiation signal resides in nucleotides 20 to 30 on the
leader RNA. To confirm this finding, two more transcripts
were made, which represent nucleotides 20–30 (L20-30)
and 20–40 (L20-40) of the leader RNA, respectively. As
shown in Fig. 5B, they are as efficiently encapsidated as
L-70. Furthermore, RNA transcripts with nucleotides
20–30 (L20-30) inhibited more than 80% of the leader
RNA encapsidation while transcripts with nucleotides
1–10 (L39-10) inhibited N encapsidation of leader RNA by
only 30% (Fig. 6).
Mapping the encapsidation site(s) on rabies virus N
protein for leader RNA
To identify the region(s) on rabies virus N that encap-
sidates rabies virus positive-strand leader RNA, six plas-
mids were made, each able to express a unique N
mutant. Three N mutants lack amino acid residues at the
N-terminus (45, 77, and 125 residues, respectively), and
three lack amino acid residues at the C-terminus (45, 78,
and 125 residues, respectively). Like the wild-type N
gene in pRN, all mutated N genes are under control of
the T7 promoter in plasmids pRN-1, pRN-2, pRN-3, pRN-4,
FIG. 3. Effects of the length of RNA on in vitro encapsidation by N. RNA transcripts representing different nucleotide lengths (L-70, L-200, L-400,
and L-800) of rabies virus positive-strand antigenomic RNA were made and labeled with [32P]UTP by in vitro transcription and interacted with rabies
virus N purified from insect cells. Each of the transcripts without N was included as a control. The complexes formed were subjected to RNase
digestion and electrophoresis on a 4% polyacrylamide gel (A). The gels were dried and autoradiographed. The banded materials were excised from
the gel and the radioactivity present was measured by scintillation spectrometry (B).
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FIG. 4. Effects of P on N encapsidation of RNA. Rabies virus positive-strand leader RNA (L-70), rabies virus N RNA (N-70), and bluescript RNA (B-70)
transcripts were made and labeled with [32P]UTP by in vitro transcription and reacted with N and P, when N and P were added either as a preformed
N–P complex (A) or as individual proteins (B). Each of the RNA transcripts was included along with N as a standard. The P protein alone was also
allowed to interact with the positive-strand leader RNA transcript (L-70, B). The complexes formed were subjected to RNase digestion and
electrophoresis on a 4% polyacrylamide gel. The gels were dried and autoradiographed.
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pRN-5, and pRN-6. To study the ability of the six N
mutants to encapsidate leader RNA, the plasmids were
used to synthesize the mutant proteins in the in vitro TnT
system. Wild-type and N mutant proteins synthesized in
the TnT system were immunoprecipitated with monoclo-
nal antibodies 377-7 (Fig. 7A) and 816-1 (data not shown),
which recognize linear epitopes at residues 374–383 and
residues 313–337 of N, respectively (Dietzschold et al.,
1987). In the TnT system, in vitro-labeled leader RNA
(L-70) was added to each of the transcription and trans-
lation mixtures. The putative RNA–N complex was immu-
noprecipitated with monoclonal antibody 377-7. RNA
from the immunoprecipitated complex was extracted and
analyzed on SDS–PAGE. Only the intact N synthesized in
the TnT system (Fig. 7B) encapsidated leader RNA, while
the N mutants with deletions from either the C- or the
N-terminus failed to encapsidate the leader RNA.
DISCUSSION
In this study, we have investigated the detailed inter-
action between rabies virus N and rabies virus-specific
positive-strand leader RNA in vitro and found that rabies
virus N preferentially encapsidates rabies virus leader
RNA. Rabies virus N binding to the positive-strand leader
RNA is 5 to 10 times stronger than to rabies virus-specific
mRNA and nonviral RNA. Furthermore, the specific en-
capsidation of leader RNA can be competitively inhibited
by unlabeled leader RNA transcript but not by nonleader
RNA transcript. Accordingly, we propose that rabies virus
N encapsidates rabies virus leader RNA, a process
which can be regarded as analogous to the initiation of
positive-strand intermediate RNA encapsidation in viral
replication. Therefore, the formation of the RNA–N com-
plex may play a critical role in the viral RNA replication
FIG. 5. Mapping the encapsidation signal on the leader RNA by N. Rabies virus leader RNA with 59 and 39 deletions are shown diagrammatically
(A) in comparison with the full-length leader RNA of 70 nucleotides. Each of the deleted leader RNA transcripts was made and labeled with [32P]UTP
by in vitro transcription and allowed to interact with recombinant N. The complexes formed were subjected to RNase digestion and electrophoresis
on a 4% polyacrylamide gel. The gels were dried and autoradiographed (B).
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process (Wunner, 1991). Similar findings have also been
reported for other negative-stranded RNA viruses, espe-
cially VSV of the Rhabdoviridae family (Blumberg et al.,
1983; Moyer et al., 1991).
Encapsidation of the positive-strand intermediate RNA
in the virus-infected cells is thought to be a dynamic
process involving the de novo synthesis of N protein and,
simultaneously, synthesis of nascent RNA. It is, however,
difficult to study the encapsidation process under the de
novo conditions. The preferential encapsidation of leader
RNA over nonleader RNA, together with the data show-
ing inhibition of leader RNA encapsidation by unlabeled
leader RNA but not by nonleader RNA, indicates that the
in vitro encapsidation, especially with short RNA tran-
scripts, may mimic the encapsidation of rabies virus RNA
in virus-infected cells. Encapsidation of longer tran-
scripts in vitro, however, may not reflect the de novo
encapsidation process since the longer RNA transcripts
may have already adopted complicated secondary or
tertiary structures. That may be the reason why the
longer RNA transcripts, resembling the positive-strand
intermediate RNA, were not efficiently encapsidated.
Moyer et al. (1991) also reported that VSV leader RNA of
129 nucleotides was not encapsidated by VSV N protein
in vitro.
From the present study, it seems that rabies virus N,
like VSV N (Blumberg et al., 1983; Moyer et al., 1991), is
capable of binding to not only leader RNA but also to
nonleader RNA (e.g., mRNA). Whereas in VSV the P
protein appears to confer specific encapsidation of
leader RNA by the N protein (Banerjee et al., 1989; Das
and Banerjee, 1992), the rabies virus P also appears to
modulate and enhance the specificity of the N encapsi-
dation of leader RNA. When P and N were added simul-
taneously to the encapsidation reaction, the encapsida-
tion of nonleader RNA by N was reduced, but the encap-
sidation of the leader RNA was not reduced. However,
the preformed N–P complex reduced the encapsidation
FIG. 6. Competition of the specific encapsidation of rabies virus positive-strand leader RNA with unlabeled shorter leader RNA transcripts. Rabies
virus positive-strand leader RNA (L-70) was made and labeled with [32P]UTP by in vitro transcription and interacted with recombinant rabies virus N
protein purified from insect cells. The transcript without N was included as a control. Unlabeled shorter leader RNA transcripts (L59-10 or L20-30) were
added into the encapsidation reaction at equal molar ratio. The complexes formed were subjected to RNase digestion and then electrophoresis on
a 4% polyacrylamide gel. The gels were dried and autoradiographed (A). The banded materials were excised from the gel and the radioactivity present
in the bands was measured by scintillation spectrometry (B).
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of not only the nonleader RNA, but also of the leader
RNA. These results may indicate that the function of P in
supporting positive-strand RNA encapsidation by N de-
pends on the de novo interaction of P and N. Previously,
we found that both the N- and the C-termini of the P are
involved in the binding of P to N. It was hypothesized that
the N-terminus of P binds to N and keeps a portion of N
available for RNA encapsidation while the C-terminal
domain of P binds to N for virus assembly (Fu et al.,
1994). Since P alone does not bind to the leader RNA, it
is possible that when both N and P are present (i.e.,
added simultaneously), the N-terminus of P binds to N,
and thus keeps the N protein available for RNA encap-
sidation. In the preformed N–P complex, N might have
already bound P through its C-terminus, as in the assem-
bled virions, thus making N incapable of encapsidating
RNA, even leader RNA, synthesized in vitro. How P con-
fers the specific encapsidation of leader RNA, but not all
other RNAs, is not clear. It is possible that N has a higher
affinity for the encapsidation signal sequence of leader
RNA than for the P protein. Furthermore, it may be that N
has a higher affinity for P than for other RNA transcripts
that lack the encapsidation signal sequence.
The encapsidation signal on the positive-strand leader
RNA of rabies virus has been mapped to within nucleo-
tides 20–30, since deletion of this sequence of nucleo-
tides from the leader RNA transcripts markedly reduced
the encapsidation efficiency to the level seen for non-
leader RNA encapsidation. 59 coterminal leader RNA
transcripts of 30, 40, 50, and 60 nucleotides were all
encapsidated as efficiently as the positive-strand leader
RNA of 70 nucleotides (L-70). In contrast, leader RNA
transcripts consisting only of the first 10 or 20 nucleo-
tides were not efficiently encapsidated. One interpreta-
tion of these results could be that the minimal number of
nucleotides needed for efficient encapsidation is greater
than 20. This appears not to be the case, since leader
RNA transcripts with deletions of the first 30 or 40 nu-
cleotides from the 59 end of the leader RNA were not
efficiently encapsidated, even though such RNA tran-
scripts each consisted of 40 and 30 nucleotides, respec-
tively. Furthermore, the RNA transcripts, which consist
respectively of only 10 nucleotides (L20-30) or 20 (L20-
40) of the leader RNA, were efficiently encapsidated.
Finally, the RNA transcript consisting of nucleotides
20–30 of the leader RNA (L20-30) inhibited the specific
encapsidation of leader RNA while the RNA transcript
consisting of nucleotides 1–10 of the leader RNA (L59-10)
did not. Together, these data indicate that the encapsi-
dation initiation signal resides within the nucleotides
20–30 of the positive-strand leader RNA.
The encapsidation initiation signal on rabies virus
leader RNA delineated in this study is different from that
reported for VSV leader RNA. Blumberg et al. (1983)
proposed that the first 14 nucleotides in the VSV leader
RNA segment carry the initiation signal for encapsidation
by N and that the repeated A residues on the first and
every third bases (ACG AAN ACN ANN AAA) of the first
14 nucleotides of the leader RNA may constitute part of
the specific encapsidation sequence of VSV. However,
Moyer et al. (1991) presented evidence that suggests that
N encapsidation of RNA is initiated within the internal
VSV sequence of the leader RNA at nucleotides 14–16,
followed by subsequent encapsidation by N protein in
both the 39 and the 59 directions. In rabies virus, an A
residue appears at the first position, but not at every third
base position thereafter (ACG CTT AAC AAC NAG) in the
first 14 nucleotides of the leader RNA sequence (Kurilla
et al., 1984; Tordo et al., 1986; Conzelmann et al., 1990).
It is therefore unlikely that the specific initiation signal for
rabies virus N protein encapsidation is similar to that of
VSV. Indeed, our data indicate that deletion of the first 20
nucleotides from the leader RNA does not affect encap-
sidation, while deletion of nucleotides 20–30 decreased
markedly the encapsidation efficiency. The sequence of
the nucleotides 20–30 of the leader RNA is 59AAG-
AAAAAACA39, which is clearly A rich. A similar A-rich
sequence is also present at nucleotides 20–30 at the 59
end of the negative-strand genomic RNA 59AAAAAT-
GAGA39 (Connzelman et al., 1990, nucleotides 11898–
11908). These A rich sequences may, therefore, consti-
tute the initiation signal for encapsidation of both rabies
virus positive- and negative-strand genomic RNA. In-
deed, an RNA transcript comprising 10 A residues
flanked by one U residue in each of the termini was
found to be efficiently encapsidated (data not shown). In
rabies virus, therefore, the N encapsidation of RNA may
FIG. 7. Encapsidation of positive-strand leader RNA with wild-type as
well as N mutants. Plasmids expressing wild-type (pRN) as well as N
mutants with deletion at either the N- (pRN1, pRN2 and pRN3) or the
C-terminus (pRN4, pRN5, and pRN6) were used for in vitro transcription
and translation. The synthesized proteins were subjected to immuno-
precipitation with anti-N monoclonal antibody 377-7 and followed by
SDS–PAGE (A). Rabies virus positive-strand leader RNA (L-70) synthe-
sized in vitro and labeled with [32P]UTP was added to each of the in
vitro transcription and translation reaction mixtures. Each of the reac-
tion mixtures was immunoprecipitated with monoclonal antibody 377-7
and the resulting complex was subjected to RNase digestion and
electrophoresis on a 4% polyacrylamide gel (B). The gels were dried
and autoradiographed.
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be initiated within the internal sequence of the leader
RNA at nucleotides 20–30, followed by subsequent en-
capsidation by N protein in both the 39 and the 59 direc-
tions as proposed for VSV by Moyer et al. (1991).
In addition, attempts were made to map the site(s) on
N that is (are) involved in encapsidation of leader RNA.
Data from this study indicate that intact N is required for
encapsidation of leader RNA, since deletion from either
the C- or the N-terminus of N abolished the ability of N to
encapsidate leader RNA transcripts. It has been pro-
posed that in VSV, the C-terminus of N plays an important
role in the encapsidation of leader RNA. Banerjee et al.
(1989) reported that the removal of as few as 10 amino
acids from the C-terminus of VSV N led to the loss of its
ability to bind to RNA. In our study, N mutants with an
intact C-terminus, but with deletions in the N-terminus,
also failed to encapsidate leader RNA, indicating that in
rabies virus, intact N is required for the encapsidation of
leader RNA.
MATERIALS AND METHODS
Proteins and antibodies
The monoclonal antibodies that reacted with rabies
virus N (377-7 and 816-1) have been previously described
(Dietzschold et al., 1987). The expression and purification
of rabies virus N, P, and N–P complexes were performed
as described previously (Fu et al., 1991, 1994). Briefly,
rabies virus N protein was purified to near homogeneity
from insect cells (Sf9) infected with recombinant baculo-
virus expressing N protein by anti-N antibody affinity
chromatography (Fu et al., 1991). The N–P complexes
were purified in the anti-N antibody affinity column by
loading insect cell lysates expressing the N followed by
those expressing the P (Fu et al., 1994). The P protein
was purified from insect cells expressing the P by affinity
chromatography using N protein as the ligand (Fu et al.,
1994).
Construction of plasmids for in vitro RNA
transcription
Two plasmids, pVRN and pVRLN, were used to pro-
duce RNA transcripts for in vitro encapsidation. Plasmids
pVRN and pVRLN were each constructed using plasmid
pV2, kindly provided by Drs. A. Ball and G. Wertz from the
University of Alabama at Birmingham (Ball, 1992). To
construct pVRN, rabies virus N protein gene was excised
from pRN (Fu et al., 1994) through XbaI digestion and
filled in with Klenow polymerase and then digested with
PstI. The recovered cDNA was subcloned into pV2, which
was digested with the StuI and PstI enzymes. To con-
struct pVRLN, two oligonucleotides (59ACGCTTAACAAC-
CAGATCAAAGAAAAAACAGACATTGTCAATTGCAA39 and
59CCATTCTAGAGGTGTTACATTTTTGCTTTGCAATTG-
ACAATGTCTGT39) were synthesized, phosphorylated
with T4 kinase, annealed, filled in with Klenow polymer-
ase, and then digested with XbaI. The resulting double-
stranded DNA (70 bp) consists of the entire rabies virus
positive-strand leader RNA, leader RNA–N mRNA junc-
tion, and the 59 untranslated sequence of N mRNA. The
double-stranded DNA was inserted into pV2 and di-
gested with StuI and XbaI. The resulting plasmid was
designated pVRL. The rabies virus N protein gene, re-
covered from pRN (Fu et al., 1994) by digestion with XbaI
and PstI, was inserted into pVRL at the same sites. This
plasmid was designated pVRLN.
To make the positive-strand viral leader RNA, pVRLN
was digested with XbaI and subjected to in vitro RNA
transcription. An RNA transcript of 72 nucleotides (L-70)
was obtained. To make a viral RNA transcript represent-
ing rabies virus positive-strand N mRNA, pVRN was used
as a template in PCR with primers V2 59, 59CCTGCGT-
TATCCCCTG39, and N3970, 59TCCACGATAATCTCAGG39.
The PCR product was used to produce an RNA transcript
of 72 nucleotides (N-70) which included the first 70 nu-
cleotides of N mRNA. Both the L-70 and the N-70 tran-
scripts contained two G’s from the T7 promoter at the
extreme 59 end, making the actual length of each of the
transcripts 72 nucleotides. A nonviral RNA transcript of
70 nucleotides (B-70) served as a control. It was gener-
ated by linearizing pBluescript II (sk)1 (Transgene) with
PstI and subjecting it to in vitro transcription.
To make positive-strand antigenomic RNA transcripts
of varying length, pVRLN was used as a template for PCR
with the following primers: V2 59, 59CCTGCGTTATC-
CCCTG39, which precedes the T7 promoter sequence,
served as the 59 end primer; while L39200, 59CTAGGGT-
TATACAGG39, L39400, 59CTCCACCAGAGAACC39; and
L39800, 59CAGTAAATGATACCA39 served as the 39 end
primers. The 59 end primer was paired with each of the
39 end primers to generate three different PCR products,
from which three RNA transcripts were then made, con-
taining 200, 400, and 800 nucleotides, respectively. All
three RNA transcripts included the leader RNA, the
leader RNA–N mRNA junction, and various amounts of
downstream N mRNA sequences.
To identify and study the encapsidation signal(s) on
the leader RNA recognized by N, different positive-strand
leader RNA transcripts with deletions at the 59 or at the
39 end were generated using PCR. To make the cDNAs
with the 39 end deletion, the following primers were
used: V2 59, 59CCTGCGTTATCCCCTG39 served as the 59
end primer; while L59-10, 59TGTTAAGCGTCCTATAGT39;
L59-20, 59TTGATCTGGTGGTTAAGC39; L59-30, 59TGTTTT-
TTCTTTGATCT39; L59-40, 59TGACAATGTVTGTTTTTT39;
L59-50, 59GCTTTGCAATTGACA39; and L59-60, 59TTA-
CATTTTTGCTTTGCA39 served as 39 end primers. The 59
end primer was paired with each of the six 39 end
primers, using pVRLN as a template. Six PCR products
were obtained, from which six RNA transcripts were
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generated, consisting of 10, 20, 30, 40, 50, and 60 nucle-
otides from the 59 end of the leader RNA, respectively.
To make deletions from the 59 end of the leader RNA,
the following primers were synthesized: one 39 end
primer, L39400, 59CTCCACCAGAGAACC39; and six 59
end primers, L39-10, 59CCGCGAAATTAATACGACTCAC-
TATAGGACCAGATCAAAGAAAAAACA39; L39-20, 59CCG-
CGAAATTAATACGACTCACTATAGGAGAAAAAACAGAC-
ATTGTCA39; L39-30, 59CCGCGAAATTAATACGACTCAC-
TATAGGGACATTGTCAATTGCAAAGC39; L39-40, 59CCGC-
GAAATTAATACGACTCACTATAGGATTGCAAAGCAAA-
AATGTAA39; L39-50, 59CCGCGAAATTAATACGACTCAC-
TATAGGAAAAATGTAACACCTTCTAGA39; and L39-60,
59CCGCGAAATTAATACGACTCACTATAGGCACCTTCT-
AGAATGGATGCC39. The 39 end primer was paired with
each of the 59 end primers, using pVRLN as template to
make six PCR products, which were digested with XbaI
and used for the in vitro transcription of six RNA tran-
scripts, with deletions of 10, 20, 30, 40, 50, and 60
nucleotides from the 59 end of the positive-strand leader
RNA, respectively.
To make constructs that express RNA of the L20-30,
L20-40, and homopoly A, the following pairs of primers
were made: Primer pair 1, 59CCGCGAAATTAATACGACT-
CACTATAGGTAAAGAAAAAAT39 and 59ATTTTTTCTTTAC-
CTATAGTG39; primer pair 2, 59CCGCGAAATTAATAC-
GACTCACTATAGGAGAAAAAACA39 and 59TGACAATGT-
CTGTTTTTTCT39; primer pair 3, 59CCGCGAAATTAATAC-
GAGTCACTATAGGTAAA39 and 59ATTTTTTTTTTACCTAT-
AGT39. Each of these primer pairs was annealed, filled in
with Klenow polymerase, and subjected to in vitro tran-
scription to make RNA transcripts of L20-30, L20-40, and
homopoly A, respectively.
RNA transcripts made from all these deletion mutants
contain similar percentages of U residues (15–20%) as
the L-70 (17%). For those constructs without U residues
(L20-30, homopoly A), one U residue was added at each
end of the transcripts to facilitate radiolabeling and to
provide a similar percentage of U residues (17%) in each
of the RNA transcripts.
Construction of plasmids for production of N mutants
The plasmid construct, pRN, used in this study has
been previously described (Fu et al., 1994). To map the
site(s) on the N protein involved in encapsidating leader
RNA, N mutants were made in which the N-terminal or
the C-terminal amino acid residues were deleted. Three
N mutants were made which lacked 45, 77, or 125 amino
acids at the N-terminus. To construct these N-terminal
deletions, one 39 end primer (59CGCCTGCAGCTTCTTAT-
GAGTC39) and three 59 end primers were synthesized (1,
59AACTCTAGAAATGGCTCCCG39; 2, 59CCTTCTAGACTA-
TATGGCAG39; and 3, 59CTGTCTAGAGGCATGGAACT39).
These 59 end primers incorporate an XbaI site for cloning
and an ATG codon at amino acid residues 46, 78, and
126, respectively, in the N sequence. After PCR with the
39 end primer and each of the 59 end primers, the PCR
products were digested with XbaI and PstI and cloned
into pGEM-3Z. These plasmids were designated pRN-1,
pRN-2, and pRN-3, respectively.
Three N mutants lacking 45, 78, or 125 amino acids at the
C-terminus were also made. To generate PCR products
with corresponding deletions, one 59 end primer (59CCT-
TCTAGAGCAATGGATGC 39) and three 39 end primers
(59CGCCTGCAGCGAGTTTAAACAG39, 59CGCCTGCAGAG-
TTAAGCCGC39, and 59 CGCCTGCAGGCTTATAGGGATC39)
were synthesized. A stop codon (TAA) was incorporated in
each of the 39 end primers. Each 39 end primer was paired
with the 59 end primer to produce the required mutants by
PCR, using pRN as template. The amplified genes were
cloned into pGEM-3Z. These plasmids were designated
pRN-4, pRN-5, and pRN-6, respectively.
In vitro RNA transcription, encapsidation, gel
retardation, and RNase protection assay
RNA transcription and labeling were carried out using
a transcription kit (Promega) according to the manufac-
turer’s specifications. Briefly, RNA was synthesized from
various T7 promoter containing constructs or PCR prod-
ucts using T7 polymerase. Each of the reactions con-
tained transcription buffer, an NTP mix (500 mM ATP,
GTP, and CTP; 12.5 mM UTP), 10 mM DTT, 100 ng tem-
plate DNA, [a-P32]UTP (800 Ci/mmol), RNasin (40 U/ml),
and T7 RNA Polymerase (10 U/ml). RNA transcription was
carried out at 37°C for 90 min. The DNA template was
digested with RNase-free DNase I (10 U/ml) at 37°C for
30 min and RNA was extracted with phenol/chloroform
and precipitated with ethanol. The radioactivity for each
reaction was determined by scintillation spectrometry.
RNA encapsidation was performed as follows: recom-
binant rabies virus N, P, or N-P complex purified from
insect cells (Fu et al., 1991, 1994) were allowed to react
with in vitro transcribed RNA (106 cpm per reaction) in
binding buffer [5 mM Hepes (pH 7.5), 25 mM KCl, 2 mM
MgCl, 0.1 mM EDTA, 2 mM DTT, 3.8% glycerol] for 15 min
at 30°C. The RNA–protein mixtures were subjected to
digestion with 2 U Micrococcal nuclease and 2 mg
RNase A at 37°C for 30 min. The reaction products were
analyzed by electrophoresis on a 4% polyacrylamide gel
containing 5% glycerol. Finally, the gel was dried and
exposed to X-ray film. In some cases, the banded mate-
rials were excised from the gel and the radioactivity was
determined.
In vitro transcription and translation reactions
The pGEM plasmids were transcribed and translated
using the TnT-coupled reticulocyte lysate system (Pro-
mega) with T7 RNA polymerase as described (Fu et al.,
1994). Briefly, 1 mg of plasmid DNA was incubated with
rabbit reticulocyte lysate, T7 RNA polymerase, amino
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acid mixture minus methionine, RNase inhibitor and
[35S]methionine (,1000 Ci/mmol, Amersham) for 90 min
at 30°C. The reaction mixture was subjected either di-
rectly to SDS–PAGE or to immunoprecipitation followed
by SDS–PAGE in 10% polyacrylamide gel as described
previously (Fu et al., 1994).
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